Company Name: |
3B Pharmachem (Wuhan) International Co.,Ltd.
|
Tel: |
821-50328103-801 18930552037 |
Email: |
3bsc@sina.com |
Products Intro: |
Product Name:L-670,596;(-)-6-8-Difluoro-2,3,4,9-tetrahydro-9-[[4-(Methylsulfonyl)phenyl]Methyl]-1H-carbazole-1-aceticacid CAS:121083-05-4 Purity:99% HPLC Package:1Mg ; 5Mg;10Mg ;100Mg;250Mg ;500Mg ;1g;2.5g ;5g ;10g
|
Company Name: |
EMMX Biotechnology LLC
|
Tel: |
888-539-0666 |
Email: |
info@emmx.com |
Products Intro: |
Product Name:L-670,596 CAS:121083-05-4 Purity:98% HPLC Package:5mg;10mg;25mg;50mg;100mg;250mg;500mg;1g
|
|
| (-)-6-8-DIFLUORO-2,3,4,9-TETRAHYDRO-9-[[4-(METHYLSULFONYL)PHENYL]METHYL]-1H-CARBAZOLE-1-ACETIC ACID Basic information |
Product Name: | (-)-6-8-DIFLUORO-2,3,4,9-TETRAHYDRO-9-[[4-(METHYLSULFONYL)PHENYL]METHYL]-1H-CARBAZOLE-1-ACETIC ACID | Synonyms: | L-670,596;(-)-6-8-DIFLUORO-2,3,4,9-TETRAHYDRO-9-[[4-(METHYLSULFONYL)PHENYL]METHYL]-1H-CARBAZOLE-1-ACETIC ACID;2-(6,8-Difluoro-9-(4-(methylsulfonyl)benzyl)-2,3,4,9-tetrahydro-1H-carbazol-1-yl)acetic acid;L670,596,L 670,596 | CAS: | 121083-05-4 | MF: | C22H21F2NO4S | MW: | 433.47 | EINECS: | | Product Categories: | Prostanoid receptor and related | Mol File: | 121083-05-4.mol | |
| (-)-6-8-DIFLUORO-2,3,4,9-TETRAHYDRO-9-[[4-(METHYLSULFONYL)PHENYL]METHYL]-1H-CARBAZOLE-1-ACETIC ACID Chemical Properties |
Boiling point | 693.4±55.0 °C(Predicted) | density | 1.43±0.1 g/cm3(Predicted) | storage temp. | Store at RT | solubility | Soluble to 100 mM in 1.1eq. NaOH | form | Powder | pka | 4.56±0.10(Predicted) |
| (-)-6-8-DIFLUORO-2,3,4,9-TETRAHYDRO-9-[[4-(METHYLSULFONYL)PHENYL]METHYL]-1H-CARBAZOLE-1-ACETIC ACID Usage And Synthesis |
Uses | L-670,596 is a potent and selective thromboxane/prostaglandin endoperoxide receptor antagonist. | Definition | ChEBI: 2-[6,8-difluoro-9-[(4-methylsulfonylphenyl)methyl]-1,2,3,4-tetrahydrocarbazol-1-yl]acetic acid is a member of carbazoles. | Biological Activity | Potent and selective thromboxane A 2 /prostaglandin endoperoxide receptor antagonist (IC 50 = 5.5 nM). Inhibits U-44069-induced contractions of guinea pig trachea (pA 2 = 9.0) and human platelet aggregation in vitro (IC 50 = 6.5 nM). Also prevents thromboxane-mediated endothelial cell death. Orally active in vivo . |
| (-)-6-8-DIFLUORO-2,3,4,9-TETRAHYDRO-9-[[4-(METHYLSULFONYL)PHENYL]METHYL]-1H-CARBAZOLE-1-ACETIC ACID Preparation Products And Raw materials |
|